Steigerwald Gordon & Koch’s Chemed CHE Stock Holding History

Steigerwald Gordon & Koch’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5	Closed	-$2.14K	–	801
2025 Q4	$2.14K	Buy	+5	New	+$2.18K	﹤0.01%	797

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Steigerwald Gordon & Koch's CHE Position: Q1 2026 in Review

Steigerwald Gordon & Koch sold out of Chemed (CHE) in Q1 2026, closing a stake of 5 shares — an estimated $2.14K sold.

Steigerwald Gordon & Koch first reported a position in CHE in Q4 2025 and held it in 1 quarter. The position peaked at $2.14K in Q4 2025. 491 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

Steigerwald Gordon & Koch reported no remaining Chemed position as of Q1 2026 after selling out during the quarter.
Steigerwald Gordon & Koch sold 5 Chemed shares in Q1 2026, an estimated $2.14K.
Steigerwald Gordon & Koch first reported a position in Chemed in Q4 2025 and held it in 1 quarter.
Steigerwald Gordon & Koch's Chemed position peaked at $2.14K in Q4 2025.
491 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q1 2026, filed 28 Apr 2026.